Medicina
Departamento
Gloria
Manso Rodríguez
Publicaciones en las que colabora con Gloria Manso Rodríguez (28)
2019
-
Medicines under additional monitoring in the European Union
Farmacia Hospitalaria, Vol. 43, Núm. 1, pp. 19-23
-
What can we learn from the public's understanding of drug information and safety? A population survey
International Journal of Pharmacy Practice, Vol. 27, Núm. 1, pp. 96-104
2018
-
The most common STOPP/START criteria in Spain. A review of the literature
Revista Espanola de Geriatria y Gerontologia, Vol. 53, Núm. 5, pp. 274-278
2017
-
Updated 2014 stopp criteria to identify potentially inappropriate prescribing in community-dwelling elderly patients
International Journal of Clinical Pharmacology and Therapeutics, Vol. 55, Núm. 10, pp. 769-773
2016
-
Beers versus STOPP criteria in polyharmacy community-dwelling older patients
Farmacia Hospitalaria, Vol. 40, Núm. 3, pp. 150-164
-
Inappropriate prescriptions in polypharmacy involving elderly outpatients. Are the STOPP criteria useful?
International Journal of Clinical Pharmacology and Therapeutics, Vol. 54, Núm. 3, pp. 172-176
-
Optimización de la información sobre la medicación de personas polimedicadas en atención primaria
Gaceta Sanitaria, Vol. 30, Núm. 1, pp. 69-72
2015
-
Spontaneous reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with antiepileptic drugs
European Review for Medical and Pharmacological Sciences, Vol. 19, Núm. 14, pp. 2732-2737
2014
-
Letter to the editor: Reporting problems related to medications in Spain. The yonotifco (I report) project, an option for citizens
International Journal of Clinical Pharmacology and Therapeutics
2013
-
La notificación directa por los pacientes de reacciones adversas a medicamentos en España
Farmacia Hospitalaria, Vol. 37, Núm. 1, pp. 65-71
-
Trends in the pharmacological treatment of osteoporosis in Spain from 2000 to 2008
Maturitas, Vol. 74, Núm. 1, pp. 74-78
2012
-
Farmacovigilancia y errores de medicación
Revista ROL de enfermería, Vol. 35, Núm. 3, pp. 8-18
2011
-
Continuous reporting of new cases in Spain supports the relationship between Herbalife® products and liver injury
Pharmacoepidemiology and Drug Safety, Vol. 20, Núm. 10, pp. 1080-1087
2010
-
Los primeros 25 años del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano
Ediciones de la Universidad de Oviedo
-
Relevancia clínica de las notificaciones de reacciones adversas de atención primaria recibidas en el centro de farmacovigilancia de Asturias
Semergen: revista española de medicina de familia, Núm. 2, pp. 63-68
2008
-
Impacto de las recomendaciones del Sistema Español de Farmacovigilancia en la publicación de casos de reacciones adversas a medicamentos
Atencion Primaria, Vol. 40, Núm. 11, pp. 555-558
-
Post-marketing safety of antineoplasic monoclonal antibodies: Rituximab and trastuzumab
Pharmacoepidemiology and Drug Safety, Vol. 17, Núm. 7, pp. 714-721
-
Spanish reports of hepatotoxicity associated with Herbalife® products
Journal of Hepatology
2007
2006
-
Safety profile of proton pump inhibitors according to the spontaneous reports of suspected adverse reactions
International Journal of Clinical Pharmacology and Therapeutics, Vol. 44, Núm. 11, pp. 548-556